Physalin H from Solanum nigrum as an Hh signaling inhibitor blocks GLI1–DNA-complex formation

Scholarly Works

• Thazhackavayal Baby, B.; Kulkarni, A. M.; Gayam, P. K. R.; Harikumar, K. B.; Aranjani, J. M. Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention. Archives of biochemistry and biophysics 2024, 754, 109952. doi:10.1016/j.abb.2024.109952
• Zhang, Q.; Yuan, Y.; Cao, S.; Kang, N.; Qiu, F. Withanolides: Promising candidates for cancer therapy. Phytotherapy research : PTR 2024, 38, 1104–1158. doi:10.1002/ptr.8090
• Bagka, M.; Choi, H.; Héritier, M.; Schwaemmle, H.; Pasquer, Q. T. L.; Braun, S. M. G.; Scapozza, L.; Wu, Y.; Hoogendoorn, S. Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog pathway inhibitor-1. Nature communications 2023, 14, 3893. doi:10.1038/s41467-023-39657-1
• Manome, T.; Hara, Y.; Ishibashi, M. A new 1,2-diketone physalin isolated from Physalis minima and TRAIL-resistance overcoming activity of physalins. Journal of natural medicines 2022, 77, 370–378. doi:10.1007/s11418-022-01670-x
• Feng, Z.; Zhu, S.; Li, W.; Yao, M.; Song, H.; Wang, R.-B. Current approaches and strategies to identify Hedgehog signaling pathway inhibitors for cancer therapy. European journal of medicinal chemistry 2022, 244, 114867. doi:10.1016/j.ejmech.2022.114867
• Bagka, M.; Choi, H.; Heritier, M.; Scapozza, L.; Wu, Y.; Hoogendoorn, S. Targeted protein degradation reveals BET bromodomains as the cellular target of Hedgehog Pathway Inhibitor-1. Cold Spring Harbor Laboratory 2022. doi:10.1101/2022.08.16.504103
• Meira, C. S.; Soares, J. W. C.; Dos Reis, B. P. Z. C.; Pacheco, L. V.; Santos, I. P.; Silva, D. K. C.; de Lacerda, J. C.; Daltro, S. R. T.; Guimarães, E. T.; Soares, M. B. P. Therapeutic Applications of Physalins: Powerful Natural Weapons. Frontiers in pharmacology 2022, 13, 864714. doi:10.3389/fphar.2022.864714
• Zhang, M.; Gao, L.-J.; Ye, Y.-P.; Li, X. Advances in glioma-associated oncogene (GLI) inhibitors for cancer therapy. Investigational new drugs 2021, 40, 1–19. doi:10.1007/s10637-021-01187-2
• Dusek, C. O.; Hadden, M. K. Targeting the GLI family of transcription factors for the development of anti-cancer drugs. Expert opinion on drug discovery 2020, 16, 289–302. doi:10.1080/17460441.2021.1832078
• Jabamalairaj, A.; Priatama, R. A.; Heo, J.; Park, S. J. Medicinal metabolites with common biosynthetic pathways in Solanum nigrum. Plant Biotechnology Reports 2019, 13, 315–327. doi:10.1007/s11816-019-00549-w
• Meng, Q.; Fan, J.-J.; Liu, Z.; Li, X.; Zhang, F.; Zhang, Y.; Sun, Y.; Li, L.; Liu, X.; Hua, E. Cytotoxic Withanolides from the Whole Herb of Physalis angulata L. Molecules (Basel, Switzerland) 2019, 24, 1608. doi:10.3390/molecules24081608
• Arai, M. A.; Ochi, F.; Makita, Y.; Chiba, T.; Higashi, K.; Suganami, A.; Tamura, Y.; Toida, T.; Iwama, A.; Sadhu, S. K.; Ahmed, F.; Ishibashi, M. GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition. ACS chemical biology 2018, 13, 2551–2559. doi:10.1021/acschembio.8b00492
• Sabol, M.; Trnski, D.; Musani, V.; Ozretić, P.; Levanat, S. Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets. International journal of molecular sciences 2018, 19, 2562. doi:10.3390/ijms19092562
• Butt, G.; Romero, M. A.; Tahir, F.; Farooqi, A. A. Emerging themes of regulation of oncogenic proteins by Solanum nigrum and its bioactive molecules in different cancers. Journal of cellular biochemistry 2018, 119, 9640–9644. doi:10.1002/jcb.27258
• Li, X.; Zhou, L.-F.; Gao, L.-J.; Wei, Y.; Xu, S.-F.; Chen, F.-Y.; Huang, W.-J.; Tan, W.-F.; Ye, Y.-P. Cynanbungeigenin C and D, a pair of novel epimers from Cynanchum bungei, suppress hedgehog pathway-dependent medulloblastoma by blocking signaling at the level of Gli. Cancer letters 2018, 420, 195–207. doi:10.1016/j.canlet.2018.02.005
• Xin, M.; Ji, X.; De La Cruz, L. K.; Thareja, S.; Wang, B. Strategies to target the Hedgehog signaling pathway for cancer therapy. Medicinal research reviews 2018, 38, 870–913. doi:10.1002/med.21482
• Bao, C.; Kramata, P.; Lee, H. J.; Suh, N. Regulation of Hedgehog Signaling in Cancer by Natural and Dietary Compounds. Molecular nutrition & food research 2017, 62, 1700621. doi:10.1002/mnfr.201700621
• Fan, J.-J.; Liu, X.; Zheng, X.-L.; Zhao, H. Y.; Xia, H.; Sun, Y. A Novel Cytotoxic Physalin from Physalis angulata. Natural Product Communications 2017, 12, 1934578X1701201. doi:10.1177/1934578x1701201016
• Arai, M. A.; Utsumi, T.; Yanase, N.; Fujimatsu, T.; Ishibashi, M. Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity. Chemical & pharmaceutical bulletin 2017, 65, 784–795. doi:10.1248/cpb.c17-00305
• Manetti, F.; Petricci, E. Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof. Expert opinion on therapeutic patents 2016, 26, 529–535. doi:10.1517/13543776.2016.1132309

Explore citations to this article at